By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
AdkhabarAdkhabarAdkhabar
Notification Show More
Font ResizerAa
  • Home
  • Automobile
  • Entertainment
  • Esports
  • Food
  • Health
  • Life Style
  • News
  • Technology
  • Travel
Reading: Global Panel Urges Rapid Reform of WHO and FCTC to Embrace Science, Transparency, and Consumer Voices
Share
Font ResizerAa
AdkhabarAdkhabar
  • Home
  • Automobile
  • Entertainment
  • Esports
  • Food
  • Health
  • Life Style
  • News
  • Technology
  • Travel
Search
  • Home
  • Automobile
  • Entertainment
  • Esports
  • Food
  • Health
  • Life Style
  • News
  • Technology
  • Travel
Follow US
Adkhabar > Blog > News > Global Panel Urges Rapid Reform of WHO and FCTC to Embrace Science, Transparency, and Consumer Voices
Global Panel Urges Rapid Reform of WHO and FCTC to Embrace Science, Transparency, and Consumer Voices
News

Global Panel Urges Rapid Reform of WHO and FCTC to Embrace Science, Transparency, and Consumer Voices

Last updated: 17/06/2025 6:44 PM
Published: 17/06/2025
Share
SHARE

WASHINGTON, June 17, 2025 /PRNewswire/ — The Taxpayers Protection Alliance (TPA) is leading a robust and candid panel discussion on Wednesday alongside the Global Forum on Nicotine in Warsaw, Poland.

- Advertisement -

Consumer advocates will issue a resounding call for urgent reform of the taxpayer-funded World Health Organization (WHO) and its tobacco control arm, the Framework Convention on Tobacco Control (FCTC). The panel argues that years of politicized policymaking, opaque governance, and disregard for consumer perspectives have rendered the FCTC increasingly ineffective and out of touch with scientific and social realities.

- Advertisement -

Calls for reform of international health institutions have intensified in recent years, with the WHO’s pandemic response drawing widespread criticism and renewed scrutiny of its broader governance failures. The FCTC has not been immune. With smoking rates not declining in many regions and growing disillusionment about the Convention’s approach, panellists say it’s time for a serious reset.

- Advertisement -

Martin Cullip, TPA International Fellow, observes that it has been clear for some time that WHO policies are missing the mark. “The FCTC has become a political instrument rather than a science-based treaty. If the WHO is serious about reform, the FCTC must be radically overhauled.”

- Advertisement -

Ignacio Leiva, President of ASOVAPE in Chile, shares his country’s perspective. “In Chile, including consumer voices helped us pass a law that recognizes the difference between smoking and vaping. That’s exactly what the FCTC needs. Evidence-based policymaking built on dialogue, not dogma.”

- Advertisement -

Nancy Loucas, representing Asian consumers, highlights the real-world harms of the WHO’s current stance. “The WHO’s policy shift against tobacco harm reduction ignores decades of evidence and disproportionately punishes low and middle-income countries. This isn’t public health, it’s health inequality.”

- Advertisement -

Consumer advocacy is a recurring theme, with speakers emphasising the importance of hearing from the people most affected by nicotine policies.

- Advertisement -

Maria Papaioannoy of Rights 4 Vapers, Canada, emphasizes that “it’s critical to counter the misinformation about safer nicotine products, especially when it comes from those in power. Consumers have voices, and it’s time they were heard at FCTC COP11.”

- Advertisement -

Tom Gleeson, Trustee of New Nicotine Alliance Ireland, echoes the call for evidence-based reform. “The FCTC hasn’t adapted since 2005 to account for safer nicotine products,” he said. “Instead, it pats itself on the back for reducing percentages while the number of smokers stays the same. The war on tobacco shouldn’t come at the cost of the very people it’s meant to help.”

- Advertisement -

The panel discussion concludes with a unified appeal. Reform must focus on transparency, scientific integrity, and consumer inclusion. Participants call on the WHO and FCTC to step away from ideological posturing and prohibitionist strategies and instead commit to pragmatic policies that save lives.

- Advertisement -

The panel’s message is clear. Real reform starts when science speaks louder than politics and when the people most affected are invited to the table.

- Advertisement -

To request interviews with a harm reduction expert, contact Kara Zupkus at kara@protectingtaxpayers.org. Watch a previous TPA webinar featuring experts here.

- Advertisement -

Logo – https://mma.prnewswire.com/media/2674819/TPA_logo.jpg 

- Advertisement -

View original content:https://www.prnewswire.co.uk/news-releases/global-panel-urges-rapid-reform-of-who-and-fctc-to-embrace-science-transparency-and-consumer-voices-302482770.html

- Advertisement -
CeraVe and L’Oral Groupe Win Prestigious IFSCC Applied Research Award for Breakthrough Dandruff Study
SimCorp to transform private market investing with SimCorp Alternatives
Bracco Imaging Receives Regulatory Approval in China for SonoVue in the Assessment of Fallopian Tube Patency
ICP DAS-BMP Attends MOU Signing Ceremony to Mark a New Milestone in Medical-Grade TPU Materials
IBM and U.S. Department of Commerce Announce America’s First Purpose-Built Quantum Foundry, Supported by Proposed $1 Billion CHIPS Award
TAGGED:andconsumerembracefctcglobalnewspanelrapidreformSciencetransparencyurgesvoiceswho
Share This Article
Facebook Email Print
- Advertisement -

Follow US

Find US on Social Medias
FacebookLike
XFollow
YoutubeSubscribe

Weekly Newsletter

Subscribe to our newsletter to get our newest articles instantly!
Popular News
ViewSonic Retains Global No. 1 Interactive Display Market Position for Third Consecutive Year
News

ViewSonic Retains Global No. 1 Interactive Display Market Position for Third Consecutive Year

13/02/2026
SED Wins VA Tech Wabag Contract for Solar Manufacturing Wastewater Recovery Project
FIS Impact Report 2024: One year into the journey
Fulcrum Therapeutics Announces Positive Initial Results from the 20 mg Dose Cohort of the Phase 1b PIONEER Trial of Pociredir in Sickle Cell Disease at the 67th American Society of Hematology Annual Meeting
Infex Therapeutics announces positive Phase IIa results for RESP-X in non-cystic fibrosis bronchiectasis patients colonised with Pseudomonas aeruginosa
- Advertisement -
- Advertisement -
- Advertisement -

Categories

  • Automobile
  • Entertainment
  • E-Sports
  • Food
  • Health
  • Technology
  • LifeStyle
  • Travel

About Us

Through our news networks, we raise millions of users' awareness. We are among the world's most reputable news networks.
Quick Link
Top Categories
  • Entertainment

Subscribe US

Subscribe to our newsletter to get our newest articles instantly!

AdkhabarAdkhabar
Copyright © 2021 - 2025 AdKhabar. All Rights Reserved. POWERED BY Life Care News.
Join Us!
Subscribe to our newsletter and never miss our latest news, podcasts etc..
Zero spam, Unsubscribe at any time.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?